Using whole genome sequencing, Selexis can generate repors to:
Read More1 min read
Whole Genome Sequencing for Cell Authentication and Determination of Product Quality
October 3, 2017
Using whole genome sequencing, Selexis can generate repors to:
Read MoreSelexis SA, a JSR Life Sciences company, is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly discover, develop and commercialize innovative medicines and vaccines. Our global partners are utilizing Selexis technologies to advance more than 160 drug products in clinical development and the manufacture of 10 commercial products. As part of a comprehensive drug development process, the Company’s technologies shorten development timelines and reduce manufacturing risks. More information is available at www.selexis.com.
Copyright© 2023 Selexis SA. All Rights Reserved.